Skip to main content
MedPathMedPath Home
Clinical Trials/IRCT20160530028182N7
IRCT20160530028182N7
Recruiting
Phase 2

Comparison Methylphenidate and Buspirone as Adjuant therapy in children with ADHD treated by Methylphenidate mono therapy

Sanandaj University of Medical Sciences0 sites50 target enrollmentTBD
Share to TwitterShare to FacebookShare to LinkedInShare to Reddit
ConditionsAttention deficit/hyperactivity disorder.Attention-deficit hyperactivity disorders

Overview

Phase
Phase 2
Intervention
Not specified
Conditions
Attention deficit/hyperactivity disorder.
Sponsor
Sanandaj University of Medical Sciences
Enrollment
50
Status
Recruiting
Last Updated
6 years ago
OverviewInvestigatorsEligibility CriteriaOutcomesSimilar Trials

Overview

Brief Summary

No summary available.

Registry
who.int
Start Date
TBD
End Date
TBD
Last Updated
6 years ago
Study Type
Interventional
Sex
All

Investigators

Sponsor
Sanandaj University of Medical Sciences

Eligibility Criteria

Inclusion Criteria

  • •Age between 6 \-12 years
  • •Diagnosis of ADHD and ODD based on DSM5
  • •without effective medication taking on mental status at least 2 weeks before the study

Exclusion Criteria

  • •Intelectual disability based on clinical suspicious
  • •presence of uncontroled siezure
  • •Drug side effects and hypersensivity
  • •Recieving of any other drugs
  • •History of psychological disorder except for ADHD and ODD
  • •presence of medical deasese such as cardiac deaseses

Outcomes

Primary Outcomes

Not specified

Similar Trials

Completed
Phase 2
Buspirone in ADHDAttention Deficit Hyperactivity Disorder.Disturbance of activity and attention
IRCT138901292000N3Behavioral Sciences and Research Center of Shahid Beheshti University of Medical Sciences.34
Recruiting
Phase 3
Comparison of opioid maintenance treatments (OMTs) in priso
IRCT20170702034844N7Faran Shimi Pharmaceutical Company100
Completed
Not Applicable
Buspirone in ADHDAttention Deficit Hyperactivity Disorder.Disturbance of activity and attention
IRCT201104116168N1euroscience Research Center Kerman University of Medical Sciences, Kerman ,Iran40
Completed
Not Applicable
the effect of buprenorphine and methadone in the reduction of methamphetamine cravingMethamphetamine Dependency.Mental and behavioural disorders due to use of other stimulants, including caffeine
IRCT2015112125160N1Shiraz University of Medical Sciences40
Not yet recruiting
Not Applicable
COMPARISON OF BUTORPHANOL VERSUS MORPHINE AS AN ADDITION TO EPIDURAL ROPIVACAINE FOR POSTOPERATIVE PAIN RELIEF IN UTERUS RELATED SURGERIESHealth Condition 1: 1- Obstetrics
CTRI/2021/12/038609SUDHAS